Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Levacetylleucine by IntraBio for Spinocerebellar Ataxia (SCA): Likelihood of Approval
Levacetylleucine is under clinical development by IntraBio and currently in Phase II for Spinocerebellar Ataxia (SCA). According to GlobalData, Phase...
Levacetylleucine by IntraBio for Ataxia-Telangiectasia (Louis-Bar Syndrome): Likelihood of Approval
Levacetylleucine is under clinical development by IntraBio and currently in Phase II for Ataxia-Telangiectasia (Louis-Bar Syndrome). According to GlobalData, Phase...
Levacetylleucine by IntraBio for Tay-Sachs Disease: Likelihood of Approval
Levacetylleucine is under clinical development by IntraBio and currently in Phase II for Tay-Sachs Disease. According to GlobalData, Phase II...